TDG Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of TDG Antibodies for investigating thymine DNA glycosylase (TDG) in various biological processes. TDG Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Thymine DNA glycosylase plays a crucial role in the base excision repair pathway by recognizing and removing mispaired thymine bases from DNA. TDG activity is essential for maintaining genomic stability and preventing mutations that could lead to various diseases, including cancer. Understanding TDG function and regulation provides key insights into DNA repair mechanisms and their impact on cellular health. Research into TDG expression patterns helps illuminate its role in different tissue types and developmental stages. Investigating TDG interactions with other proteins reveals important details about DNA repair pathway coordination. Studying TDG modifications and activity levels aids in understanding disease progression and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DNA repair mechanisms and their implications in human health and disease.